Global Pulmonary Arterial Hypertension (PAH) Market : Opportunities and Forecasts (2016-2021)
MarketResearchReports.biz has recently announced the addition of a market study “ Global Pulmonary Arterial Hypertension (PAH) Market (By Drug Class, By Region, By Country): Opportunities and Forecasts (2016-2021) – (By Drug Class -Endothelin Receptor Antagonists, Prostacyclin & Prostacyclin Analogs, Phosphodiesterase V Inhibitors, Others; By Region-North America, Europe, APAC, Latin America, MEA; By Country- USA, Canada, UK, Germany, Japan, Brazil, South Africa) ”, is a comparative analysis of the global market.
A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of the global Pulmonary Arterial Hypertension (PAH) market on the basis of Drug Class (Endothelin Receptor Antagonists, Prostacyclin, Prostacyclin Analogs, Phosphodiesterase V Inhibitors, Others), By Region (North America, Europe, APAC, Latin America, MEA) and By Country (USA, Canada, UK, Germany, Japan, Brazil, South Africa).
The report suggests that rising development of pipeline drugs in PAH combined with the growing awareness of the disease majorly in developed countries has resulted in the growth of PAH market. Also, the market for Pulmonary Arterial Hypertension (PAH) is growing moderately due to newer launches of pipeline drugs that target different pathways to supress the symptoms of the disease. Early diagnosis of the disease has played a pivotal role in number of patients undergoing treatment.
Among the drug classes, the market is expected to be driven by ERAs. However, growing number of drugs under prostacyclin are expected to witness tremendous growth in the forecast period.
While developed regions will continue to dominate the market in terms of revenue, emerging nations are expected to respond to the market optimistically due to the developing healthcare infrastructure and rising focus on healthcare among the growing middle class population. Global Pulmonary Arterial Hypertension Market is forecasted to grow at a CAGR of 4.95% during 2016 – 2021F, on account of rising prevalence of the PAH disease among the population.
North America region remains the major market followed by Europe in the actual period. In the forecast period, APAC region will witness strong growth driven by the countries such as India and China.
Download The sample Copy Of This Report: http://www.marketresearchreports.biz/sample/sample/791867
According to Azoth Analytics research report, Global Pulmonary Arterial Hypertension Market: Trends, Opportunities and Forecasts (2016-2021), Global Pulmonary Arterial Hypertension market is projected to exhibit a CAGR of over ~4.95% during 2016 – 2021. On the basis of market segment, Global Pulmonary Arterial Hypertension Market has been segmented By Drug Class (Endothelin Receptor Antagonists, Prostacyclin, Prostacyclin Analogs, Phosphodiesterase V Inhibitors, Others; By Region-North America, Europe, APAC, Latin America, MEA; By Country- USA, Canada, UK, Germany, Japan, Brazil, South Africa)
Scope of the Report
The report provides Segmentation by Drug Class
Endothelin receptor antagonists
Prostacyclin and Prostacyclin Analogs
Phosphodiesterase V Inhibitors
The report provides coverage by Region
Middle East and Africa (MEA)
The report provides coverage by Country
Customization of the Report
The report could be customized according to the client’s specific research requirements. No additional cost will be required to pay for limited additional research.
Table of Contents
1. Research Methodology
2. Executive Summary
3. Strategic Recommendations
3.1. PAH Market to Grow at a Moderate Rate
3.2. ERA to the Drive the PAH Market
3.3. PAH Market to be Dominated by North America and Europe
4. Global PAH Market: An Overview
4.1. Product Overview
4.1.1. Global PAH Market, By Value 2011-2015
4.1.2. Global PAH Market, By Value 2016-2021F
4.1.3 Global PAH Market: By Drug Class Type, By Value (2016E-2021F)
Global PAH Market: By Type (Endothelin receptor antagonists, Prostacyclin and Prostacyclin Analogs, Phosphodiesterase V Inhibitors and others)
4.2. Global Endothelin Receptor Antagonist Market
4.2.1. By Value (Historic 2011-15)
4.2.2. By Value (Forecast 2016E-2021F)
4.3. Global Prostacyclin and Prostacyclin Analogs Market
4.3.1. By Value (Historic 2011-15)
4.3.2. By Value (Forecast 2016E-2021F)
4.4. Global Phosphodiesterase V Inhibitors Market
4.4.1. By Value (Historic 2011-15)
4.4.2. By Value (Forecast 2016E-2021F)
4.5. Global Other Drugs Market
4.5.1. By Value (Historic 2011-15)
4.5.2. By Value (Forecast 2016E-2021F)
4.6. PAH Drugs Pipeline Analysis
MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.
Read our latest Press Releases at http://www.marketresearchreports.biz/pressreleases
90 State Street, Suite 700
Albany, NY 12207
USA: Canada Toll Free: 866-997-4948
Follow us on LinkedIn: https://www.linkedin.com/company/marketresearchreports-biz